Dr. Mohammed Kashani-Sabet

Dr. Mohammed Kashani-Sabet (DR. MOHAMMED KASHANI-SABET ) is A Dermatology Physician in San Francisco, CA. The NPI Number for Dr. Mohammed Kashani-Sabet is 1629026174.

The current location address for Dr. Mohammed Kashani-Sabet is 2340 CLAY STREET 2ND FLOOR San Francisco, CA 94115 and the contact number is 4156003800 and fax number is 4156003865. The mailing address for Dr. Mohammed Kashani-Sabet is 2340 CLAY STREET 2ND FLOOR San Francisco, CA 94115- 4156003800 (mailing address contact number - 4156003800).

A dermatologist is trained to diagnose and treat pediatric and adult patients with benign and malignant disorders of the skin, mouth, external genitalia, hair and nails, as well as a number of sexually transmitted diseases. The dermatologist has had additional training and experience in the diagnosis and treatment of skin cancers, melanomas, moles and other tumors of the skin, the management of contact dermatitis and other allergic and nonallergic skin disorders, and in the recognition of the skin manifestations of systemic (including internal malignancy) and infectious diseases. Dermatologists have special training in dermatopathology and in the surgical techniques used in dermatology. They also have expertise in the management of cosmetic disorders of the skin such as hair loss and scars and the skin changes associated with aging.

What is the NPI Number for Dr. Mohammed Kashani-Sabet ?

Answer: The NPI Number for Dr. Mohammed Kashani-Sabet is 1629026174

Where is Dr. Mohammed Kashani-Sabet located?

Answer: Dr. Mohammed Kashani-Sabet is located at 2340 CLAY STREET 2ND FLOOR San Francisco, CA 94115.

What is the specialty for Dr. Mohammed Kashani-Sabet ?

Answer: The Specialty of Dr. Mohammed Kashani-Sabet is A Dermatology Physician.

Are there any online reviews for Dr. Mohammed Kashani-Sabet ?

Answer: Yes! Check It Now.

Are there any other health care providers in San Francisco, CA?

Answer: Yes, there are given below...

Information on services and procedures provided to Original Medicare (fee-for-service) Part B (Medical Insurance) beneficiaries by Dr. Mohammed Kashani-Sabet

Number of HCPCS	14
Number of Medicare Beneficiaries	443
Number of Services	1521
Total Submitted Charge Amount	294304
Total Medicare Allowed Amount	116811.82
Total Medicare Payment Amount	84385.18
Total Medicare Standardized Payment Amount	68386.27
Drug Suppress Indicator
Number of HCPCS Associated With Drug Services	0
Number of Medicare Beneficiaries With Drug Services	0
Number of Drug Services	0
Total Drug Submitted Charge Amount	0
Total Drug Medicare Allowed Amount	0
Total Drug Medicare Payment Amount	0
Total Drug Medicare Standardized Payment Amount	0
Medical Suppress Indicator
Number of HCPCS Associated With Medical Services	14
Number of Medicare Beneficiaries With Medical	443
Number of Medical Services	1521
Total Medical Submitted Charge Amount	294304
Total Medical Medicare Allowed Amount	116811.82
Total Medical Medicare Payment Amount	84385.18
Total Medical Medicare Standardized Payment Amount	68386.27
Average Age of Beneficiaries	74
Number of Beneficiaries Age Less 65
Number of Beneficiaries Age 65 to 74	231
Number of Beneficiaries Age 75 to 84	171
Number of Beneficiaries Age Greater 84
Number of Female Beneficiaries	189
Number of Male Beneficiaries	254
Number of Non-Hispanic White Beneficiaries	405
Number of Black or African American Beneficiaries
Number of Asian Pacific Islander Beneficiaries
Number of Hispanic Beneficiaries
Number of American Indian/Alaska Native Beneficiaries
Number of Beneficiaries With Race Not Elsewhere Classified	23
Number of Beneficiaries With Medicare & Medicaid Entitlement	12
Number of Beneficiaries With Medicare Only Entitlement	431
Percent (%) of Beneficiaries Identified With Atrial Fibrillation	0.1
Percent (%) of Beneficiaries Identified With Alzheimer's Disease or Dementia	0.05
Percent (%) of Beneficiaries Identified With Asthma	0.05
Percent (%) of Beneficiaries Identified With Cancer	0.13
Percent (%) of Beneficiaries Identified With Heart Failure	0.09
Percent (%) of Beneficiaries Identified With Chronic Kidney Disease	0.19
Percent (%) of Beneficiaries Identified With Chronic Obstructive Pulmonary Disease	0.05
Percent (%) of Beneficiaries Identified With Depression	0.11
Percent (%) of Beneficiaries Identified With Diabetes	0.12
Percent (%) of Beneficiaries Identified With Hyperlipidemia	0.53
Percent (%) of Beneficiaries Identified With Hypertension	0.49
Percent (%) of Beneficiaries Identified With Ischemic Heart Disease	0.24
Percent (%) of Beneficiaries Identified With Osteoporosis	0.09
Percent (%) of Beneficiaries Identified With Rheumatoid Arthritis / Osteoarthritis	0.33
Percent (%) of Beneficiaries Identified With Schizophrenia / Other Psychotic Disorders	0
Percent (%) of Beneficiaries Identified With Stroke	0.02
Average HCC Risk Score of Beneficiaries	1.1661

Information on prescription drugs provided to Medicare beneficiaries enrolled in Part D (Prescription Drug Coverage), by physicians and other health care providers, aggregated by provider.

Provider Specialty Type	Dermatology
Source of Provider Specialty
Number of Medicare Part D Claims, Including Refills	40
Number of Standardized 30-Day Fills	54.466666667
Aggregate Cost Paid for All Claims	3322.89
Number of Day's Supply for All Claims	1481
Number of Medicare Beneficiaries	16
Number of Claims, Including Refills, for Beneficiaries Age 65+	40
Including Refills, for Beneficiaries Age 65+	54.466666667
Beneficiaries Age 65+	3322.89
Number of Day's Supply for All Claims for Beneficaries Age 65+	1481
Number of Medicare Beneficiaries Age 65+	16
Reason for Suppression of Brnd_Tot_Clms and Brnd_Tot_Drug_Cst
Total Claims of Brand-Name Drugs	0
Reason for Suppression of Gnrc_Tot_Clms and Gnrc_Tot_Drug_Cst
Total Claims of Generic Drugs, Including Refills	40
Aggregate Cost Paid for Generic Drugs	3322.89
Reason for Suppression of Othr_Tot_Clms and Othr_Tot_Drug_Cst
Total Claims of Other Drugs, Including Refills	0
Aggregate Cost Paid for Other Drugs	0
Reason for Suppression of MAPD_Tot_Clmsand MAPD_Tot_Drug_Cst
Number of Claims for Beneficiaries Covered by MAPD Plans	14
Aggregate Cost Paid for Claims Filled by Beneficiaries in MAPD Plans	1220.63
Reason for Suppression of PDP_Tot_Clms and PDP_Tot_Drug_Cst
Number of Claims for Beneficiaries Covered by Standalone PDP Plans	26
Aggregate Cost Paid for Claims Filled by	2102.26
Reason for Suppression of LIS_Tot_Clms and LIS_Drug_Cst	*
Number of Claims for Beneficiaries Covered by Low-Income Subsidy
Aggregate Cost Paid for Claims Covered by Low-Income Subsidy
Reason for Suppression of NonLIS_Tot_Clms and NonLIS_Drug_Cst	#
Number of Claims for Beneficiaries Not Covered by Low-Income Subsidy
by Low-Income Subsidy
Total Claims of Opioid Drugs, Including	0
Aggregate Cost Paid for Opioid Drugs	0
Opioid Claims	0
Opioid_Tot_Clms divided by the Tot_Clms	0
Total Claims of Long-Acting Opioid Drugs	0
Aggregate Cost Paid for Long-Acting Opioid	0
Number of Day's Supply of All Long-Acting	0
Long-Acting Opioid Claims	0
Opioid_LA_Tot_Clms divided by the
Total Claims of Antibiotic Drugs, Including	0
Aggregate Cost Paid for Antibiotic Drugs	0
Antibiotic Claims	0
Reason for Suppression of Antpsyct_GE65_Tot_Clms and Antpsyct_GE65_Tot_Drug_Cst
Including Refills, for Beneficiaries Age 65+	0
Aggregate Cost Paid for AntipsychoticDrugs for Beneficiaries Age 65+	0
Reason for Suppression of Antpsyct_GE65_Tot_Benes
Number of Medicare Beneficiaries Age 65+Filling Antipsychotic Claims	0
Average Age of Beneficiaries	75.0625
Number of Beneficiaries Age Less Than 65	0
Number of Beneficiaries Age 65 to 74
Number of Beneficiaries Age 75 to 84
Number of Female Beneficiaries
Number of Male Beneficiaries
Number of Non-Hispanic White	14
Number of Black or African American	0
Number of Asian Pacific Islander
Number of Hispanic Beneficiaries	0
Number of American Indian/Alaskan NativeBeneficiaries	0
Number of Beneficiaries with Race Not
Only Entitlement
Average Hierarchical Condition Category	1.1031875